Literature DB >> 22011318

Sweet syndrome in children.

Lily C Uihlein1, Heather A Brandling-Bennett, Peter A Lio, Marilyn G Liang.   

Abstract

The objective of this study was to describe the clinical features of Sweet syndrome in children. Our study population consisted of seven children diagnosed with Sweet syndrome over a 22-year period. Age, sex, appearance and location of lesions, associated signs and symptoms, past medical history, pathology, and subsequent disease course were documented for each patient. Fever and typical lesions were reported in most of patients in our study. The majority of patients presented with less-typical findings, such as pustules, vesicles, bullae, oral ulcerations, atrophic scars, and evidence of pathergy. Of the seven children in our study, four were found to have a preceding nonspecific upper respiratory or gastrointestinal infection, and two were diagnosed with an underlying hematologic malignancy. Our results suggest that atypical lesions are relatively common in children with Sweet syndrome and that underlying malignancy is associated with a minority of cases of pediatric Sweet syndrome.
© 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 22011318     DOI: 10.1111/j.1525-1470.2011.01534.x

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  6 in total

1.  Sweet Syndrome in Pediatric Acute Myeloid Leukemia.

Authors:  Vahakn S Keskinyan; David H Noyd; Caroline M Underwood; David Van Mater
Journal:  J Pediatr Hematol Oncol       Date:  2021-01       Impact factor: 1.170

2.  Periodic Fever and Neutrophilic Dermatosis: Is It Sweet's Syndrome?

Authors:  Raheleh Assari; Vahid Ziaee; Nima Parvaneh; Mohammad-Hassan Moradinejad
Journal:  Case Reports Immunol       Date:  2014-12-04

Review 3.  Myeloid sarcoma in children - diagnostic and therapeutic difficulties.

Authors:  Magdalena Samborska; Katarzyna Derwich; Jolanta Skalska-Sadowska; Paweł Kurzawa; Jacek Wachowiak
Journal:  Contemp Oncol (Pozn)       Date:  2017-01-12

4.  Ptpn6 inhibits caspase-8- and Ripk3/Mlkl-dependent inflammation.

Authors:  Mary Speir; Cameron J Nowell; Alyce A Chen; Joanne A O'Donnell; Isaac S Shamie; Paul R Lakin; Akshay A D'Cruz; Roman O Braun; Jeff J Babon; Rowena S Lewis; Meghan Bliss-Moreau; Inbar Shlomovitz; Shu Wang; Louise H Cengia; Anca I Stoica; Razq Hakem; Michelle A Kelliher; Lorraine A O'Reilly; Heather Patsiouras; Kate E Lawlor; Edie Weller; Nathan E Lewis; Andrew W Roberts; Motti Gerlic; Ben A Croker
Journal:  Nat Immunol       Date:  2019-12-09       Impact factor: 25.606

5.  Sweet Syndrome in an Adolescent Patient With Differentiation Syndrome Secondary to Promyelocytic Leukemia Treatment With All-Trans Retinoic Acid.

Authors:  Jorge Luis Ramirez Melo; Rosa Margarita Cruz Osorio; Jessica Santoyo Cueva; Fernando Sanchez Zubieta; Pablo Alejandro Chavez; Luis Tonatiuh Fernandez Mendoza; Felipe de Jesus Bustos Rodriguez; Christian David Burbano Figueroa; Johana Alexandra Burbano Figueroa
Journal:  J Med Cases       Date:  2021-12-02

6.  Histiocytoid Sweet Syndrome in a Child without Underlying Systemic Disease.

Authors:  Seung Dohn Yeom; Hye Soo Ko; Jong Hyuk Moon; Min Ji Kang; Ji Won Byun; Gwang Seong Choi; Jeonghyun Shin
Journal:  Ann Dermatol       Date:  2017-08-25       Impact factor: 1.444

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.